NCT02686697View on ClinicalTrials.gov

Carnosine and Cognitive Training in Schizophrenia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

July 19, 2022

Study Completion Date

July 19, 2022

Conditions
Schizophrenia
Interventions
DRUG

L-Carnosine

DRUG

Placebo

BEHAVIORAL

Cognitive Training

Cognitive Training for 2 weeks

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Abraham Reichenberg

OTHER

NCT02686697 - Carnosine and Cognitive Training in Schizophrenia | Biotech Hunter | Biotech Hunter